Sunday, 21 June 2020

Cipla Gets Regulatory Nod To Make COVID-19 Drug, Shares Hit Record High

Cipla shares surged over 9% after it got an approval from DCGI to manufacture and market generic COVID-19 drug Remdesivir.

from NDTV Profit - Latest https://ift.tt/2NjBVTT
via
on
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)